Functional Regulation of Ginsenosides on Myeloid Immunosuppressive Cells in the Tumor Microenvironment

Yanfei Zhang1, Zhidong Qiu1, Ye Qiu2

  • 1Changchun University of Chinese Medicine, Changchun, Jilin, People's Republic of China.

Insights

Ginsenosides from ginseng show promise in cancer treatment by targeting tumor cells and boosting immune responses. This review explores their role in modulating myeloid immunosuppressive cells within the tumor microenvironment for novel cancer therapies.

Area of Science:

  • Natural Products Chemistry
  • Immunology
  • Cancer Biology

Background:

  • Ginsenosides, derived from ginseng, are recognized for their antitumor properties.
  • Existing research highlights their direct effects on cancer cells, including apoptosis induction and growth inhibition.
  • Their impact on enhancing anti-tumor immunity via T lymphocytes and natural killer cells is also documented.

Purpose of the Study:

  • To investigate the less-understood functions of ginsenosides on myeloid immunosuppressive cells.
  • To explore the role of ginsenosides in modulating dendritic cells, tumor-associated macrophages, and myeloid-derived suppressor cells.
  • To provide insights into novel therapeutic strategies for cancer treatment by targeting these myeloid cells.

Main Methods:

  • Literature review of existing studies on ginsenosides and myeloid cells in the tumor microenvironment.
  • Analysis of research detailing the regulatory functions of ginsenosides on immunosuppressive myeloid cell populations.
  • Synthesis of information on how ginsenosides influence angiogenesis, invasion, and metastasis via these cells.

Main Results:

  • Ginsenosides exhibit regulatory effects on various myeloid immunosuppressive cells within the tumor microenvironment.
  • These compounds influence key processes such as tumor angiogenesis, invasion, and metastasis.
  • Understanding these interactions opens avenues for ginsenoside-based cancer therapies.

Conclusions:

  • Ginsenosides represent a potential therapeutic agent for modulating the tumor microenvironment.
  • Targeting myeloid immunosuppressive cells with ginsenosides offers a novel approach to cancer treatment.
  • Further research into ginsenoside mechanisms can lead to improved clinical outcomes in oncology.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K